SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Cerenome to Present Interim Update on ReSPECT-LM Trial

Cerenome says it will present an interim clinical update on the ReSPECT-LM trial of multiple REYOBIQ doses in leptomeningeal metastases.

CNSY
SquawkNews Desk 1 updates Updated Oct 27, 2026, 11:33 AM UTC

Story updates

11:33:57 AM UTC
SquawkNews
Company to provide latest clinical trial data and highlight evolving approaches to leptomeningeal metastases diagnosis and treatment in a company sponsored symposium2026 SNO Annual Meeting to be held on November 12-15 in PhiladelphiaHOUSTON, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Cerenome, Inc. NASDAQ:C…

Related stories

Megan Holdings Closes $7.5 Million Follow-on Public Offering Megan Holdings Limited said it closed a $7.5 million follow-on public offering. M impact | EQUITY | Oct 29, 2026, 03:12 PM UTC Bausch Health Hits 52-Week High After Quarterly Earnings Bausch Health reached $11.89, a 52-week high. Its quarterly earnings were $1.77 per share, compared with the Zacks consensus estimate of $1.08 and $1.16 a year earlier. M impact | EQUITY | Oct 29, 2026, 03:11 PM UTC Jordan Decapolis Properties Reports Q3 Loss of 22,762 Dinars M impact | EQUITY | Oct 29, 2026, 03:11 PM UTC Microsoft Guides for Q2 Revenue of $96 Billion to $97.1 Billion Microsoft expects revenue and Azure growth to accelerate in the December quarter as delayed AI infrastructure spending shifts into the fiscal year's second half. Its Q2 revenue gui M impact | EQUITY | Oct 29, 2026, 03:11 PM UTC PHINIA Reports Quarterly Sales of $912M, Net Earnings of $67M PHINIA reported quarterly net sales of $912 million and net earnings of $67 million, compared with $908 million and $13 million a year earlier. Diluted EPS was $1.80, up from $0.33 M impact | EQUITY | Oct 29, 2026, 03:11 PM UTC Iovance shares fall more than 32% after updated lung cancer trial results Shares fell more than 32% on Thursday, putting the stock on track for its worst session since May 2025. The sell-off followed updated lung cancer trial results. M impact | EQUITY | Oct 29, 2026, 03:11 PM UTC